What is Fetal Valproate Syndrome

Fetal Valproate Syndrome (FVS) is a condition that occurs in babies who were exposed to the medication valproate during pregnancy. Valproate is commonly prescribed to treat epilepsy and bipolar disorder. FVS is characterized by a range of physical, cognitive, and developmental abnormalities that can vary in severity from one individual to another.

Physical features associated with FVS may include facial abnormalities such as a flattened nose bridge, thin upper lip, and small eyes. Additionally, babies with FVS may have limb defects, such as shorter or fused fingers or toes.

Cognitive and developmental issues are also common in individuals with FVS. They may experience learning difficulties, delayed speech and language development, and lower IQ scores compared to their peers. Some individuals may also exhibit behavioral problems, such as attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).

It is important for healthcare providers to be aware of a pregnant woman's use of valproate and to carefully weigh the risks and benefits of continuing the medication during pregnancy. If you have concerns about FVS or valproate use during pregnancy, it is recommended to consult with a healthcare professional for personalized advice.